Idioma: Inglés
Publicado por TFM Publishing Ltd, GB, 2010
ISBN 10: 1903378710 ISBN 13: 9781903378717
Librería: Rarewaves.com USA, London, LONDO, Reino Unido
EUR 58,43
Cantidad disponible: 10 disponibles
Añadir al carritoHardback. Condición: New. Practising evidence-based medicine necessarily depends on the clinician having access to the best evidence available, but in a fast-moving field, keeping up to date with the latest developments is a challenging prospect. In this new volume, leading experts focus on the most important clinical issues associated with the management of Lipid Disorders, evaluating and interpreting the evidence available to provide the reader with a reliable summary of our current knowledge. Topics covered include therapeutic strategies for managing hereditary lipid disorders, including familial hypercholesterolaemia, both in adults and children, and familial combined hypercholesterolaemia. The authors also evaluate the evidence for a link between inflammatory disease and cardiovascular risk; the metabolic syndrome and the interconnections between dyslipidaemias and diabetes. They also look at therapeutic challenges such as the management of patients who are statin resistant, and the control of lipid levels in those suffering renal insufficiency. Tables highlight important data, evidence from trial results and expert reports, and each section concludes with a series of Key Points that present a summary of evidence-based recommendations for best practice, graded according to the quality of that evidence. The book provides the busy clinician with a unique analysis of the data supporting current therapies and will help the reader formulate effective strategies for treating their own patients.
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Original o primera edición
EUR 51,78
Cantidad disponible: 20 disponibles
Añadir al carritoCondición: New. Focuses on clinical issues that are associated with the management of lipid disorders. This book includes such topics as therapeutic strategies for managing hereditary lipid disorders, including familial hypercholesterolaemia, both in adults and children, and familial combined hypercholesterolaemia. Num Pages: 314 pages, tables & charts. BIC Classification: MJH. Category: (P) Professional & Vocational. Dimension: 251 x 179 x 23. Weight in Grams: 1048. . 2010. 1st Edition. Hardcover. . . . .
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
EUR 63,63
Cantidad disponible: 20 disponibles
Añadir al carritoCondición: New. Focuses on clinical issues that are associated with the management of lipid disorders. This book includes such topics as therapeutic strategies for managing hereditary lipid disorders, including familial hypercholesterolaemia, both in adults and children, and familial combined hypercholesterolaemia. Num Pages: 314 pages, tables & charts. BIC Classification: MJH. Category: (P) Professional & Vocational. Dimension: 251 x 179 x 23. Weight in Grams: 1048. . 2010. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.
Idioma: Inglés
Publicado por TFM Publishing Ltd, GB, 2010
ISBN 10: 1903378710 ISBN 13: 9781903378717
Librería: Rarewaves USA, OSWEGO, IL, Estados Unidos de America
EUR 86,24
Cantidad disponible: 10 disponibles
Añadir al carritoHardback. Condición: New. Practising evidence-based medicine necessarily depends on the clinician having access to the best evidence available, but in a fast-moving field, keeping up to date with the latest developments is a challenging prospect. In this new volume, leading experts focus on the most important clinical issues associated with the management of Lipid Disorders, evaluating and interpreting the evidence available to provide the reader with a reliable summary of our current knowledge. Topics covered include therapeutic strategies for managing hereditary lipid disorders, including familial hypercholesterolaemia, both in adults and children, and familial combined hypercholesterolaemia. The authors also evaluate the evidence for a link between inflammatory disease and cardiovascular risk; the metabolic syndrome and the interconnections between dyslipidaemias and diabetes. They also look at therapeutic challenges such as the management of patients who are statin resistant, and the control of lipid levels in those suffering renal insufficiency. Tables highlight important data, evidence from trial results and expert reports, and each section concludes with a series of Key Points that present a summary of evidence-based recommendations for best practice, graded according to the quality of that evidence. The book provides the busy clinician with a unique analysis of the data supporting current therapies and will help the reader formulate effective strategies for treating their own patients.
Idioma: Inglés
Publicado por TFM Publishing Ltd (UK), 2010
ISBN 10: 1903378710 ISBN 13: 9781903378717
Librería: Gazelle Books, Lancaster, LANCA, Reino Unido
EUR 44,61
Cantidad disponible: 20 disponibles
Añadir al carritoHardback. Condición: New. New Book, Direct from Publisher.
Librería: BennettBooksLtd, Los Angeles, CA, Estados Unidos de America
EUR 118,93
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: New. In shrink wrap. Looks like an interesting title!
Idioma: Inglés
Publicado por TFM Publishing Ltd, GB, 2010
ISBN 10: 1903378710 ISBN 13: 9781903378717
Librería: Rarewaves.com UK, London, Reino Unido
EUR 54,45
Cantidad disponible: 10 disponibles
Añadir al carritoHardback. Condición: New. Practising evidence-based medicine necessarily depends on the clinician having access to the best evidence available, but in a fast-moving field, keeping up to date with the latest developments is a challenging prospect. In this new volume, leading experts focus on the most important clinical issues associated with the management of Lipid Disorders, evaluating and interpreting the evidence available to provide the reader with a reliable summary of our current knowledge. Topics covered include therapeutic strategies for managing hereditary lipid disorders, including familial hypercholesterolaemia, both in adults and children, and familial combined hypercholesterolaemia. The authors also evaluate the evidence for a link between inflammatory disease and cardiovascular risk; the metabolic syndrome and the interconnections between dyslipidaemias and diabetes. They also look at therapeutic challenges such as the management of patients who are statin resistant, and the control of lipid levels in those suffering renal insufficiency. Tables highlight important data, evidence from trial results and expert reports, and each section concludes with a series of Key Points that present a summary of evidence-based recommendations for best practice, graded according to the quality of that evidence. The book provides the busy clinician with a unique analysis of the data supporting current therapies and will help the reader formulate effective strategies for treating their own patients.
Idioma: Inglés
Publicado por TFM Publishing Ltd, GB, 2010
ISBN 10: 1903378710 ISBN 13: 9781903378717
Librería: Rarewaves USA United, OSWEGO, IL, Estados Unidos de America
EUR 88,87
Cantidad disponible: 10 disponibles
Añadir al carritoHardback. Condición: New. Practising evidence-based medicine necessarily depends on the clinician having access to the best evidence available, but in a fast-moving field, keeping up to date with the latest developments is a challenging prospect. In this new volume, leading experts focus on the most important clinical issues associated with the management of Lipid Disorders, evaluating and interpreting the evidence available to provide the reader with a reliable summary of our current knowledge. Topics covered include therapeutic strategies for managing hereditary lipid disorders, including familial hypercholesterolaemia, both in adults and children, and familial combined hypercholesterolaemia. The authors also evaluate the evidence for a link between inflammatory disease and cardiovascular risk; the metabolic syndrome and the interconnections between dyslipidaemias and diabetes. They also look at therapeutic challenges such as the management of patients who are statin resistant, and the control of lipid levels in those suffering renal insufficiency. Tables highlight important data, evidence from trial results and expert reports, and each section concludes with a series of Key Points that present a summary of evidence-based recommendations for best practice, graded according to the quality of that evidence. The book provides the busy clinician with a unique analysis of the data supporting current therapies and will help the reader formulate effective strategies for treating their own patients.